0001628280-26-012895
SEC filingInfuSystem Holdings, Inc. furnished an Investor Presentation under Item 7.01 detailing 2025 financial results including record net revenues of $143.4 million and Adjusted EBITDA of $31.5 million, segment performance, balance sheet strength, and capital allocation including a $20 million share repurchase program. The disclosure provides investors with updated operating and financial metrics through December 31, 2025.